MIKEL
TAINTA CUEZVA
University Hospital of Geneva
Ginebra, SuizaPublications en collaboration avec des chercheurs de University Hospital of Geneva (15)
2023
-
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Genome Medicine, Vol. 15, Núm. 1
-
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits
Alzheimer's and Dementia, Vol. 19, Núm. 6, pp. 2317-2331
2022
-
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI
Human Brain Mapping, Vol. 43, Núm. 6, pp. 1821-1835
-
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation
Molecular Psychiatry, Vol. 27, Núm. 4, pp. 1990-1999
2021
-
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia
Alzheimer's and Dementia, Vol. 17, Núm. 3, pp. 500-514
-
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 92, Núm. 6, pp. 608-616
-
Replication study of plasma proteins relating to Alzheimer's pathology
Alzheimer's and Dementia, Vol. 17, Núm. 9, pp. 1452-1464
2020
-
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology
Journal of Alzheimer's Disease, Vol. 77, Núm. 3, pp. 1353-1368
-
Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
Translational Psychiatry, Vol. 10, Núm. 1
-
Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
Journal of Alzheimer's Disease, Vol. 74, Núm. 1, pp. 213-225
2019
-
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 5, pp. 933-938
-
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
Alzheimer's and Dementia, Vol. 15, Núm. 5, pp. 644-654
-
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
Alzheimer's and Dementia, Vol. 15, Núm. 11, pp. 1478-1488
-
Inflammatory biomarkers in Alzheimer's disease plasma
Alzheimer's and Dementia, Vol. 15, Núm. 6, pp. 776-787
-
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
Alzheimer's and Dementia, Vol. 15, Núm. 6, pp. 817-827